Clinical Trial Update: Open-Label Study Evaluating Synera® in the Treatment of Patients With Carpal Tunnel Syndrome [Phase 2]

View source ↗

Summary

Open-label Phase 2 study evaluating Synera in the treatment of Carpal Tunnel Syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carpal Tunnel Syndrome

Drugs mentioned

• Synera (lidocaine/tetracaine patch)

Snippet

Sponsor: ZARS Pharma Inc. | Conditions: Carpal Tunnel Syndrome | Phase 2 | Status: COMPLETED